Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Transdermal Systems for Agitation in Alzheimer's Dementia
NCT06052254Phase 2Active, not recruiting
- Start
- Sep 2025
- Primary completion
- May 2027
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine in agitation. Started Sep 2025; status: active, not recruiting.
02
Drugs
dexmedetomidine
03
Conditions
agitation
Beyond the preview
Go deeper on NCT06052254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06052254.